Treatment with NPC-CM showed some benefits in reducing the level of apoptosis, with the expression of Bax and Bcl2 mRNAs playing a regulatory role in the processes of apoptosis, resulting in a moderate effect on viability. This evidence concerns the gene BAX and nasopharyngeal carcinoma.